GENEVA, Feb. 3 -- CSPC MEGALITH BIOPHARMACEUTICAL CO., LTD. (519, Cangsheng Road, High-Tech Development ZoneShijiazhuang, Hebei 050025), 石药集团巨石生物制药有限公司 (中国河北省石家庄市高新区仓盛路519号) filed a patent application (PCT/CN2024/107156) for "PHARMACEUTICAL COMPOSITION CONTAINING RECOMBINANT HUMANIZED ANTI-CD73 MONOCLONAL ANTIBODY" on Jul 24, 2024. With publication no. WO/2025/021098, the details related to the patent application was published on Jan 30, 2025.
Notably, the patent application was submitted under the International Patent Classification...